Join to View Full Profile
3400 Spruce StFl 5Philadelphia, PA 19104
Phone+1 215-662-2454
Fax+1 215-662-7527
Dr. Bili is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Rochester Medical CenterFellowship, Rheumatology, 1996 - 1999- University of Rochester Medical CenterResidency, Internal Medicine, 1994 - 1996
Zucker School of Medicine at Hofstra/NorthwellInternship, Internal Medicine, 1993 - 1994
Aristotle University of Thessaloniki School of MedicineClass of 1990
Certifications & Licensure
PA State Medical License 2006 - 2026
VA State Medical License 2002 - 2008
WV State Medical License 2002 - 2002
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- "Learning About Biologics"-Rheumatoid Arthritis Start of enrollment: 2012 Nov 01
Publications & Presentations
PubMed
- 7 citationsA phase 3, multicenter, randomized, double-blind study to evaluate the interchangeability of V114, a 15-valent pneumococcal conjugate vaccine, and PCV13 with respect t...Androniki Bili, Scott Dobson, Jeffrey Quinones, Wanatpreeya Phongsamart, Peninnah Oberdorfer
Vaccine. 2023-01-16 - 17 citationsA phase I randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and immunogenicity of a live-attenuated quadrivalent dengue vaccine ...Kevin L Russell, Richard E Rupp, Javier O Morales-Ramirez, Clemente Diaz-Perez, Charles P Andrews
Human Vaccines & Immunotherapeutics. 2022-11-30 - 13 citationsLong-term safety and efficacy of sirukumab for patients with rheumatoid arthritis who previously received sirukumab in randomised controlled trials (SIRROUND-LTE).Daniel Aletaha, Clifton O. Bingham, George Karpouzas, Tsutomu Takeuchi, Carter Thorne
RMD Open. 2021-01-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
